Research Reports

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Dabur India Q1 Review - Peaked Out Performance: Prabhudas Lilladher

Prism Johnson - Lockdown-Hit Performance In Q1; Expansion To Help: Anand Rathi

Gokaldas Exports Q1 Review - Structural Long Term Play In Apparel Export Space: ICICI Direct

Finolex Industries Q1 Review - Lower Sales Volume Weighed On Quarterly Results: IDBI Capital

PI Industries Q1 Review - Broadening Its Horizon With Active Pharma Ingredient Acquisition: Motilal Oswal

Blue Dart Q1 Review - Start Of Normalisation As The Bulge Fades: ICICI Securities

Zydus Wellness Q1 Review - Good Quarter With Improving Margin Trajectory: ICICI Securities

Rossari Biotech Q1 Review - Value Extraction From Inorganic Growth Key: ICICI Securities

Southwest Monsoon IMD Update - Monsoon Likely To Exceed Normal In 2021: ICRA

CDSL Q1 Review - More Likely On A Cyclical Top: ICICI Securities

Windlas Biotech IPO - Competitive Strengths, Key Risks, Concerns: ICICI Direct

EIH Q1 Review - Passing Through Medium Term Challenges: ICICI Direct

Cholamandalam Investment Q1 Review - Restructured Assets At 5.4%; Asset Quality To Improve: IDBI Capital

Q1 Interim Earnings Review - In-Line; Management Commentaries Indicate Recovery Is Setting In: Motilal Oswal

Action Construction Equipment Q1 Review - Sturdy Performance: ICICI Direct

Top Picks, Investment Strategy For August - Healthy Performance; Sustainability Is The Key: Axis Securities

RBL Bank Q1 Review - Elevated Provisioning Drives Loss; Watchful Of Near-Term Asset Quality: Motilal Oswal

Emami Q1 Review - Improved Visibility But High Base Quarters Ahead: Prabhudas Lilladher

Nazara Technologies Q1 Review - Result Beat, Profitability Sees Sharp Uptick: Dolat Capital

Devyani International IPO - Strengths, Key Strategies, Risks: Anand Rathi

Britannia Q1 Review - Positive Surprise In Revenue: Dolat Capital

V-Guard Industries - Covid-19 Impacts Q1; Inventory Goes Up: Dolat Capital

KEI Industries Q1 Review - Growth Momentum To Continue: Prabhudas Lilladher

PI Industries Q1 Review - Time To Replicate Proven Capabilities Of Agchem In Pharma: Prabhudas Lilladher

HDFC Q1 Review - Restructured Assets At 0.9%; Collection Efficiency At Pre-Covid-19 Levels: IDBI Capital

Varun Beverages Q2 Review - Sharp Volume Growth On Strong Recovery, Lower Base: Motilal Oswal

Devyani International IPO - Execution Key For Long-Term, Listing Gains Likely: Prabhudas Lilladher

Vinati Organics Q1 Review - Gross Margin Guidance Revised Down; Revenue Potential Intact: Motilal Oswal

Kansai Nerolac Q1 Review - Below Expected; Inflation Remains Chief Concern: IDBI Capital

Emami Q1 Review - Margin Outlook Getting Better; Sales Recovery Key To Re-Rating: Motilal Oswal

RBL Bank Q1 Review - Elevated Provisions Result In Loss: Dolat Capital

HDFC Q1 Review - Steady Operations; Business To Pick Up From Here On: ICICI Direct

Cholamandalam Finance Q1 Review - Demand Growing, Provision Roll-Backs Likely In H2 FY22E: Systematix

HDFC Q1 Review - In-Line Operating Profit; Commentary Suggests Healthy Revival From Second Wave: Motilal Oswal

Britannia Q1 Review - Sales Momentum Healthy; ICD Reduction A Significant Positive: Motilal Oswal

Britannia Q1 Review - Milk Bikis Tracks Well; Focus To Be On Premiumising Growth: IDBI Capital

PVR Q1 Review - Curtailed Opex To Limit Losses; Gradual Re-Opening In Sight: Motilal Oswal

Visaka Industries - Healthy Demand Outlook: Anand Rathi

NTPC Q1 Review - Transitioning Towards Greener Side: ICICI Direct

LIC Housing Finance Q1 Review - Weak Asset Quality Outweighs Multiple Other Positives: Nirmal Bang

Dabur India Q1 Review - Peaked Out Performance: Prabhudas Lilladher

Prism Johnson - Lockdown-Hit Performance In Q1; Expansion To Help: Anand Rathi

Gokaldas Exports Q1 Review - Structural Long Term Play In Apparel Export Space: ICICI Direct

Finolex Industries Q1 Review - Lower Sales Volume Weighed On Quarterly Results: IDBI Capital

PI Industries Q1 Review - Broadening Its Horizon With Active Pharma Ingredient Acquisition: Motilal Oswal

Blue Dart Q1 Review - Start Of Normalisation As The Bulge Fades: ICICI Securities

Zydus Wellness Q1 Review - Good Quarter With Improving Margin Trajectory: ICICI Securities

Rossari Biotech Q1 Review - Value Extraction From Inorganic Growth Key: ICICI Securities

Southwest Monsoon IMD Update - Monsoon Likely To Exceed Normal In 2021: ICRA

CDSL Q1 Review - More Likely On A Cyclical Top: ICICI Securities

Windlas Biotech IPO - Competitive Strengths, Key Risks, Concerns: ICICI Direct

EIH Q1 Review - Passing Through Medium Term Challenges: ICICI Direct

Cholamandalam Investment Q1 Review - Restructured Assets At 5.4%; Asset Quality To Improve: IDBI Capital

Q1 Interim Earnings Review - In-Line; Management Commentaries Indicate Recovery Is Setting In: Motilal Oswal

Action Construction Equipment Q1 Review - Sturdy Performance: ICICI Direct

Top Picks, Investment Strategy For August - Healthy Performance; Sustainability Is The Key: Axis Securities

RBL Bank Q1 Review - Elevated Provisioning Drives Loss; Watchful Of Near-Term Asset Quality: Motilal Oswal

Emami Q1 Review - Improved Visibility But High Base Quarters Ahead: Prabhudas Lilladher

Nazara Technologies Q1 Review - Result Beat, Profitability Sees Sharp Uptick: Dolat Capital

Devyani International IPO - Strengths, Key Strategies, Risks: Anand Rathi

Britannia Q1 Review - Positive Surprise In Revenue: Dolat Capital

V-Guard Industries - Covid-19 Impacts Q1; Inventory Goes Up: Dolat Capital

KEI Industries Q1 Review - Growth Momentum To Continue: Prabhudas Lilladher

PI Industries Q1 Review - Time To Replicate Proven Capabilities Of Agchem In Pharma: Prabhudas Lilladher

HDFC Q1 Review - Restructured Assets At 0.9%; Collection Efficiency At Pre-Covid-19 Levels: IDBI Capital

Varun Beverages Q2 Review - Sharp Volume Growth On Strong Recovery, Lower Base: Motilal Oswal

Devyani International IPO - Execution Key For Long-Term, Listing Gains Likely: Prabhudas Lilladher

Vinati Organics Q1 Review - Gross Margin Guidance Revised Down; Revenue Potential Intact: Motilal Oswal

Kansai Nerolac Q1 Review - Below Expected; Inflation Remains Chief Concern: IDBI Capital

Emami Q1 Review - Margin Outlook Getting Better; Sales Recovery Key To Re-Rating: Motilal Oswal

RBL Bank Q1 Review - Elevated Provisions Result In Loss: Dolat Capital

HDFC Q1 Review - Steady Operations; Business To Pick Up From Here On: ICICI Direct

Cholamandalam Finance Q1 Review - Demand Growing, Provision Roll-Backs Likely In H2 FY22E: Systematix

HDFC Q1 Review - In-Line Operating Profit; Commentary Suggests Healthy Revival From Second Wave: Motilal Oswal

Britannia Q1 Review - Sales Momentum Healthy; ICD Reduction A Significant Positive: Motilal Oswal

Britannia Q1 Review - Milk Bikis Tracks Well; Focus To Be On Premiumising Growth: IDBI Capital

PVR Q1 Review - Curtailed Opex To Limit Losses; Gradual Re-Opening In Sight: Motilal Oswal

Visaka Industries - Healthy Demand Outlook: Anand Rathi

NTPC Q1 Review - Transitioning Towards Greener Side: ICICI Direct

LIC Housing Finance Q1 Review - Weak Asset Quality Outweighs Multiple Other Positives: Nirmal Bang

Indian Indices
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
No Data
*Delayed data from stock exchanges.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.